{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:42:39Z","timestamp":1793698959730,"version":"4.5.1"},"reference-count":116,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong Province","doi-asserted-by":"publisher","award":["2022TZXD0033"],"award-info":[{"award-number":["2022TZXD0033"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong Province","doi-asserted-by":"publisher","award":["24-1-8-smjk-20-nsh"],"award-info":[{"award-number":["24-1-8-smjk-20-nsh"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2024LMB015"],"award-info":[{"award-number":["ZR2024LMB015"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023MC099"],"award-info":[{"award-number":["ZR2023MC099"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bbadis.2025.168102","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:04:07Z","timestamp":1762272247000},"page":"168102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Revisiting the metabolic crosstalk between type 2 diabetes and hyperuricemia: Pathophysiological insights and therapeutic perspectives"],"prefix":"10.1016","volume":"1872","author":[{"given":"Xiuqiang","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changsong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianya","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2025.168102_bb0005","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bbadis.2025.168102_bb0010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41581-020-0278-5","article-title":"Genetics of diabetes mellitus and diabetes complications","volume":"16","author":"Cole","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bbadis.2025.168102_bb0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11154-023-09787-4","article-title":"Mechanistic insights of soluble uric acid-induced insulin resistance: insulin signaling and beyond","volume":"24","author":"Yu","year":"2023","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.bbadis.2025.168102_bb0020","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41392-024-01916-y","article-title":"Hyperuricemia and its related diseases: mechanisms and advances in therapy","volume":"9","author":"Du","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2025.168102_bb0025","first-page":"31","article-title":"Insights into renal damage in hyperuricemia: focus on renal protection (review)","author":"Yang","year":"2025","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbadis.2025.168102_bb0030","doi-asserted-by":"crossref","first-page":"e685","DOI":"10.1016\/S2214-109X(24)00012-3","article-title":"The gout epidemic in French Polynesia: a modelling study of data from the ma\u2019i u\u2019u epidemiological survey","volume":"12","author":"Pascart","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.bbadis.2025.168102_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.995582","article-title":"Recent progress and perspectives on the relationship between hyperuricemia and periodontitis","volume":"13","author":"Hou","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2025.168102_bb0040","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2478\/jtim-2022-0031","article-title":"Prevalence and risk factors of hyperuricemia and gout: a cross-sectional survey from 31 provinces in mainland China","volume":"10","author":"Song","year":"2022","journal-title":"J Transl Int Med"},{"key":"10.1016\/j.bbadis.2025.168102_bb0045","article-title":"Association between serum uric acid and dyslipidaemia in type 2 diabetes: a cross-sectional study","volume":"15","author":"Zhao","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.bbadis.2025.168102_bb0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11892-023-01506-2","article-title":"Prevalence of diabetes in patients with hyperuricemia and gout: a systematic review and meta-analysis","volume":"23","author":"Jiang","year":"2023","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.bbadis.2025.168102_bb0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12902-023-01408-0","article-title":"Prevalence of hyperuricemia among type 2 diabetes mellitus patients in africa: a systematic review and meta-analysis","volume":"23","author":"Alemayehu","year":"2023","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.bbadis.2025.168102_bb0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13098-025-01586-y","article-title":"Exploring the prevalence of gout among underrepresented low socioeconomic status type 2 diabetes populations","volume":"17","author":"Smith","year":"2025","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.bbadis.2025.168102_bb0065","doi-asserted-by":"crossref","DOI":"10.1177\/20420188231198620","article-title":"Prevalence and associated factors of hyperuricemia among chinese patients with diabetes: a cross-sectional study","volume":"14","author":"Sun","year":"2023","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2025.168102_bb0070","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2147\/DMSO.S399343","article-title":"The mechanism of sodium-glucose cotransporter-2 inhibitors in reducing uric acid in type 2 diabetes mellitus","volume":"16","author":"Dong","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.bbadis.2025.168102_bb0075","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.numecd.2023.02.018","article-title":"Distinct hyperuricemia trajectories are associated with different risks of incident diabetes: a prospective cohort study","volume":"33","author":"Liu","year":"2023","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.bbadis.2025.168102_bb0080","doi-asserted-by":"crossref","first-page":"13447","DOI":"10.1021\/acs.nanolett.4c04267","article-title":"Wearable hydrogel SERS chip utilizing plasmonic trimers for uric acid analysis in sweat","volume":"24","author":"Li","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.bbadis.2025.168102_bb0085","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12902-022-01112-5","article-title":"Correlation of obesity, dietary patterns, and blood pressure with uric acid: data from the NHANES 2017-2018","volume":"22","author":"Yao","year":"2022","journal-title":"BMC Endocr. Disord."},{"issue":"7","key":"10.1016\/j.bbadis.2025.168102_bb0090","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/ajh\/hpaf031","article-title":"Correlation between metabolic syndrome and hyperuricemia: a systematic review and meta-analysis","volume":"38","author":"Fan","year":"2025","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.bbadis.2025.168102_bb0095","doi-asserted-by":"crossref","first-page":"e1098","DOI":"10.1016\/S2468-2667(24)00251-2","article-title":"Diabetes in China part 2: prevention, challenges, and progress","volume":"9","author":"Xu","year":"2024","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.bbadis.2025.168102_bb0100","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ecl.2021.05.013","article-title":"An update on the epidemiology of type 2 diabetes: a global perspective","volume":"50","author":"Tinajero","year":"2021","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"10.1016\/j.bbadis.2025.168102_bb0105","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s12020-024-03772-w","article-title":"Early onset type 2 diabetes mellitus: an update","volume":"85","author":"Strati","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.bbadis.2025.168102_bb0110","article-title":"Associations between urate-lowering therapy and the risk of type 2 diabetes mellitus","volume":"14","author":"Chang","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2025.168102_bb0115","article-title":"Evaluating the risk of developing hyperuricemia in patients with type 2 diabetes mellitus using least absolute shrinkage and selection operator regression and machine learning algorithm","volume":"10","author":"Chen","year":"2024","journal-title":"Digit Health"},{"key":"10.1016\/j.bbadis.2025.168102_bb0120","doi-asserted-by":"crossref","DOI":"10.1177\/11795514241274694","article-title":"Prevalence of hyperuricemia and associated factors among patients with type 2 diabetes mellitus in northwestern tanzania: a cross-sectional study","volume":"17","author":"Abdel","year":"2024","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"10.1016\/j.bbadis.2025.168102_bb0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00424-021-02606-2","article-title":"Hyperuricemia-induced endothelial insulin resistance: the nitric oxide connection","volume":"474","author":"Bahadoran","year":"2022","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.bbadis.2025.168102_bb0130","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/art.41779","article-title":"Assessing the causal relationships between insulin resistance and hyperuricemia and gout using bidirectional mendelian randomization","volume":"73","author":"McCormick","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bbadis.2025.168102_bb0135","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1681\/ASN.0000000000000054","article-title":"Genetic and physiological effects of insulin-like growth factor-1 (IGF-1) on human urate homeostasis","volume":"34","author":"Mandal","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbadis.2025.168102_bb0140","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186633","article-title":"Gene-environment interaction modifies the association between hyperinsulinemia and serum urate levels through SLC22a12","volume":"135","author":"Fujii","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2025.168102_bb0145","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/art.42940","article-title":"Caffeine inhibits both basal and insulin-activated urate transport","volume":"76","author":"Mandal","year":"2024","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bbadis.2025.168102_bb0150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12889-023-17471-0","article-title":"Insufficient compensatory pancreatic beta-cells function might be closely associated with hyperuricemia in u.s. adults: evidence from the national health and nutrition examination survey","volume":"24","author":"Shen","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.bbadis.2025.168102_bb0155","article-title":"RBP4 is associated with insulin resistance in hyperuricemia-induced rats and patients with hyperuricemia","volume":"12","author":"Liu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.bbadis.2025.168102_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.582680","article-title":"Uric acid and cardiovascular disease: an update from molecular mechanism to clinical perspective","volume":"11","author":"Yu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.168102_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179221","article-title":"Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease","volume":"22","author":"Yanai","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.168102_bb0170","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.2147\/DMSO.S429068","article-title":"Effect of intestinal flora on hyperuricemia-induced chronic kidney injury in type 2 diabetic patients and the therapeutic mechanism of new anti-diabetic prescription medications","volume":"16","author":"Yan","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.bbadis.2025.168102_bb0175","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12902-021-00698-6","article-title":"Uric acid-induced pancreatic beta-cell dysfunction","volume":"21","author":"Ghasemi","year":"2021","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.bbadis.2025.168102_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063188","article-title":"Uric acid and oxidative stress-relationship with cardiovascular, metabolic, and renal impairment","volume":"23","author":"Gherghina","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2025.168102_bb0185","article-title":"The role of oxidative stress in hyperuricemia and xanthine oxidoreductase (XOR) inhibitors","volume":"2021","author":"Liu","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbadis.2025.168102_bb0190","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017492","article-title":"Cardiometabolic risk factors and preclinical target organ damage among adults in Ghana: findings from a national study","volume":"9","author":"Li","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbadis.2025.168102_bb0195","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023301","article-title":"Weak association between genetic markers of hyperuricemia and cardiorenal outcomes: insights from the STANISLAS study cohort with a 20-year follow-up","volume":"11","author":"Kanbay","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbadis.2025.168102_bb0200","first-page":"13","article-title":"Exploring the multifaceted nexus of uric acid and health: a review of recent studies on diverse diseases","author":"Kuwabara","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbadis.2025.168102_bb0205","doi-asserted-by":"crossref","first-page":"12619","DOI":"10.1039\/D2FO02431D","article-title":"Ganoderma lucidum polysaccharide peptide alleviates hyperuricemia by regulating adenosine deaminase and urate transporters","volume":"13","author":"Lin","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.bbadis.2025.168102_bb0210","first-page":"13","article-title":"Host-derived lactobacillus plantarum alleviates hyperuricemia by improving gut microbial community and hydrolase-mediated degradation of purine nucleosides","author":"Fu","year":"2024","journal-title":"Elife"},{"key":"10.1016\/j.bbadis.2025.168102_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2024.115234","article-title":"Integrated microbiome and metabolome analysis reveals the key role of taurohyocholate in the treatment of hyperuricemia with lacticaseibacillus rhamnosus 2016SWU.05.0601","volume":"197","author":"Chen","year":"2024","journal-title":"Food Res. Int."},{"key":"10.1016\/j.bbadis.2025.168102_bb0220","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/postmj\/qgad081","article-title":"Uric acid and diabetes mellitus: an update","volume":"99","author":"Singh","year":"2023","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.bbadis.2025.168102_bb0225","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1080\/10408398.2022.2119934","article-title":"Probiotics, bioactive compounds and dietary patterns for the effective management of hyperuricemia: a review","volume":"64","author":"Sun","year":"2024","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.bbadis.2025.168102_bb0230","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1186\/s12889-023-16669-6","article-title":"A predictive model for hyperuricemia among type 2 diabetes mellitus patients in urumqi, China","volume":"23","author":"Abudureyimu","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/j.bbadis.2025.168102_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.863064","article-title":"Development and internal validation of a risk model for hyperuricemia in diabetic kidney disease patients","volume":"10","author":"Huang","year":"2022","journal-title":"Front. Public Health"},{"key":"10.1016\/j.bbadis.2025.168102_bb0240","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1038\/s41591-023-02610-2","article-title":"Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin a1c","volume":"29","author":"Zhou","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2025.168102_bb0245","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12933-023-01761-3","article-title":"Prevalence of prediabetes and undiagnosed diabetes in a large urban middle-aged population: the CARVAR 92 cohort","volume":"22","author":"Hauguel-Moreau","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbadis.2025.168102_bb0250","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/acps.13687","article-title":"Development and validation of a machine learning model for prediction of type 2 diabetes in patients with mental illness","volume":"151","author":"Bernstorff","year":"2025","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.bbadis.2025.168102_bb0255","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1021\/acs.jafc.1c07851","article-title":"Metabolites of gut microbiota and possible implication in development of diabetes mellitus","volume":"70","author":"Guo","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbadis.2025.168102_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110567","article-title":"Lower-than-normal glycemic levels to achieve optimal reduction of diabetes risk among individuals with prediabetes: a prospective cohort study","volume":"197","author":"Lin","year":"2023","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbadis.2025.168102_bb0265","article-title":"Performance of the 1 h oral glucose tolerance test in predicting type 2 diabetes and association with impaired beta-cell function in asians: a national prospective cohort study","volume":"54","author":"Lee","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.bbadis.2025.168102_bb0270","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/s41591-022-02055-z","article-title":"Proteomic signatures for identification of impaired glucose tolerance","volume":"28","author":"Carrasco-Zanini","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2025.168102_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.113865","article-title":"The role of lipid profile in the relationship between particulate matters and hyperuricemia: a prospective population study","volume":"214","author":"Zeng","year":"2022","journal-title":"Environ. Res."},{"key":"10.1016\/j.bbadis.2025.168102_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.116631","article-title":"Exposure to ambient air pollutants is associated with an increased incidence of hyperuricemia: a longitudinal cohort study among chinese government employees","volume":"235","author":"Duan","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.bbadis.2025.168102_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131989","article-title":"Rationalization design, soluble expression and PEG modification of highly active recombinant human-porcine uricase mutant protein","volume":"269","author":"Tong","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbadis.2025.168102_bb0290","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.4103\/jfmpc.jfmpc_777_24","article-title":"Association of serum uric acid levels with glycated haemoglobin in diabetic patients and healthy controls","volume":"13","author":"Patel","year":"2024","journal-title":"J. Family Med. Prim. Care"},{"key":"10.1016\/j.bbadis.2025.168102_bb0295","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2147\/DMSO.S454711","article-title":"Fractional excretion of urate is positively associated with type 2 diabetes in HUA patients: a cross-sectional study","volume":"17","author":"Huang","year":"2024","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.bbadis.2025.168102_bb0300","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/jdi.14120","article-title":"Decline in measured glomerular filtration rate is associated with simple renal cyst in chinese patients with type 2 diabetes","volume":"15","author":"Qiaoling","year":"2024","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.bbadis.2025.168102_bb0305","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1039\/D4FO00760C","article-title":"Anti-hyperuricemia bioactive peptides: a review on obtaining, activity, and mechanism of action","volume":"15","author":"Chen","year":"2024","journal-title":"Food Funct."},{"key":"10.1016\/j.bbadis.2025.168102_bb0310","article-title":"Non-coronary peripheral arterial complications in people with type 2 diabetes: a swedish retrospective cohort study","volume":"39","author":"Rawshani","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.bbadis.2025.168102_bb0315","first-page":"13","article-title":"A possible therapeutic application of the selective inhibitor of urate transporter 1, dotinurad, for metabolic syndrome, chronic kidney disease, and cardiovascular disease","author":"Yanai","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2025.168102_bb0320","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1001\/jamacardio.2022.5608","article-title":"Association of dapagliflozin use with clinical outcomes and the introduction of uric acid-lowering therapy and colchicine in patients with heart failure with and without gout: a patient-level pooled meta-analysis of DAPA-HF and DELIVER","volume":"8","author":"Butt","year":"2023","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.bbadis.2025.168102_bb0325","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1111\/dom.15895","article-title":"Effects of ertugliflozin on uric acid and gout-related outcomes in persons with type 2 diabetes and cardiovascular disease: post hoc analyses from VERTIS CV","volume":"26","author":"Sridhar","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbadis.2025.168102_bb0330","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1111\/dom.15157","article-title":"Serum uric acid lowering and effects of sodium-glucose cotransporter-2 inhibitors on gout: a meta-analysis and meta-regression of randomized controlled trials","volume":"25","author":"Banerjee","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbadis.2025.168102_bb0335","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/dom.15310","article-title":"The effect of metformin on urate metabolism: findings from observational and mendelian randomization analyses","volume":"26","author":"Dai","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbadis.2025.168102_bb0340","doi-asserted-by":"crossref","first-page":"213","DOI":"10.15537\/smj.2025.46.3.20240920","article-title":"Effects of antidiabetic drugs on the level of serum uric acid in patients who have type 2 diabetes","volume":"46","author":"Wang","year":"2025","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.bbadis.2025.168102_bb0345","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","article-title":"Bempedoic acid and cardiovascular outcomes in statin-intolerant patients","volume":"388","author":"Nissen","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2025.168102_bb0350","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1111\/dom.13361","article-title":"Semaglutide for type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"20","author":"Andreadis","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.bbadis.2025.168102_bb0355","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2025.168102_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.731370","article-title":"A head-to-head comparison of benzbromarone and allopurinol on the risk of type 2 diabetes mellitus in people with asymptomatic hyperuricemia","volume":"12","author":"Lai","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2025.168102_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11549","article-title":"Effect of low dose allopurinol on glycemic control and glycemic variability in patients with type 2 diabetes mellitus: a cross-sectional study","volume":"8","author":"Alem","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.bbadis.2025.168102_bb0370","doi-asserted-by":"crossref","DOI":"10.1177\/15593258221123677","article-title":"Allopurinol use and the risk of type 2 diabetes mellitus: a meta-analysis of cohort studies","volume":"20","author":"Lai","year":"2022","journal-title":"Dose-Response"},{"key":"10.1016\/j.bbadis.2025.168102_bb0375","doi-asserted-by":"crossref","first-page":"19966","DOI":"10.1021\/acs.jmedchem.4c01260","article-title":"Recent progress and future perspectives on anti-hyperuricemic agents","volume":"67","author":"Sun","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbadis.2025.168102_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2024.139444","article-title":"Food-derived bioactive peptides with anti-hyperuricemic activity: a comprehensive review","volume":"451","author":"Mehmood","year":"2024","journal-title":"Food Chem."},{"key":"10.1016\/j.bbadis.2025.168102_bb0385","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1039\/D2BM01836E","article-title":"Transdermal delivery of allopurinol to acute hyperuricemic mice via polymer microneedles for the regulation of serum uric acid levels","volume":"11","author":"Wang","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bbadis.2025.168102_bb0390","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1002\/ptr.8229","article-title":"Saponin monomers: potential candidates for the treatment of type 2 diabetes mellitus and its complications","volume":"38","author":"Zhang","year":"2024","journal-title":"Phytother. Res."},{"issue":"6","key":"10.1016\/j.bbadis.2025.168102_bb0395","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/nutrit\/nuae136","article-title":"Phytoactives for obesity management: integrating nanomedicine for its effective delivery","volume":"83","author":"Mandal","year":"2025","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.bbadis.2025.168102_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.138421","article-title":"Natural polysaccharides in the prevention of hyperuricemia: source, classification, mechanism, application in food industry","volume":"286","author":"Ren","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbadis.2025.168102_bb0405","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.1039\/D4FO02391A","article-title":"A metabolomics perspective reveals the mechanism of the uric acid-lowering effect of prunus salicina lindl. Cv. \u201cfurong\u201d polyphenols in hypoxanthine and potassium oxybate-induced hyperuricemic mice","volume":"15","author":"Wu","year":"2024","journal-title":"Food Funct."},{"key":"10.1016\/j.bbadis.2025.168102_bb0410","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1002\/ptr.8020","article-title":"Natural compounds against nonalcoholic fatty liver disease: a review on the involvement of the LKB1\/AMPK signaling pathway","volume":"37","author":"Omidkhoda","year":"2023","journal-title":"Phytother. Res."},{"key":"10.1016\/j.bbadis.2025.168102_bb0415","doi-asserted-by":"crossref","first-page":"15647","DOI":"10.1021\/acs.jafc.2c06554","article-title":"Research progress of natural active substances with uric-acid-reducing activity","volume":"70","author":"Zhang","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbadis.2025.168102_bb0420","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1021\/acs.jafc.2c01513","article-title":"Naringenin ameliorates hyperuricemia by regulating renal uric acid excretion via the PI3k\/AKT signaling pathway and renal inflammation through the NF-kappab signaling pathway","volume":"71","author":"Yang","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbadis.2025.168102_bb0425","doi-asserted-by":"crossref","first-page":"12169","DOI":"10.1039\/D4FO03481C","article-title":"Mulberry (fructus mori) extract alleviates hyperuricemia by regulating urate transporters and modulating the gut microbiota","volume":"15","author":"Fang","year":"2024","journal-title":"Food Funct."},{"key":"10.1016\/j.bbadis.2025.168102_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113091","article-title":"Regulation of the intestinal flora: a potential mechanism of natural medicines in the treatment of type 2 diabetes mellitus","volume":"151","author":"He","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2025.168102_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156402","article-title":"Gut microbiota as a new target for hyperuricemia: a perspective from natural plant products","volume":"138","author":"Dong","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbadis.2025.168102_bb0440","article-title":"Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via IRS2-proteasome degradation","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2025.168102_bb0445","article-title":"Urate-lowering effect of delphinidin-3-glucoside in red kidney beans via binding to the FAD site of the XO enzyme","author":"Chen","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bbadis.2025.168102_bb0450","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1038\/s41380-022-01804-3","article-title":"Analysis of hyperforin (St. John\u2019s wort) action at TRPC6 channel leads to the development of a new class of antidepressant drugs","volume":"27","author":"El Hamdaoui","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbadis.2025.168102_bb0455","article-title":"The cellular and molecular targets of natural products against metabolic disorders: a translational approach to reach the bedside","volume":"2024","author":"Shen","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.bbadis.2025.168102_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.107040","article-title":"Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide","volume":"199","author":"Lunati","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbadis.2025.168102_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155305","article-title":"Data mining-guided alleviation of hyperuricemia by paeonia veitchii lynch through inhibition of xanthine oxidase and regulation of renal urate transporters","volume":"124","author":"Du","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bbadis.2025.168102_bb0470","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1002\/ptr.8211","article-title":"Herbal remedies in the management of hyperuricemia and gout: a review of in vitro, in vivo and clinical evidences","volume":"38","author":"Mahomoodally","year":"2024","journal-title":"Phytother. Res."},{"key":"10.1016\/j.bbadis.2025.168102_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114445","article-title":"Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment","volume":"188","author":"Gao","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbadis.2025.168102_bb0480","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00394-019-02147-6","article-title":"Improving type 2 diabetes mellitus glycaemic control through lifestyle modification implementing diet intervention: a systematic review and meta-analysis","volume":"59","author":"Garcia-Molina","year":"2020","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.bbadis.2025.168102_bb0485","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/wvn.12608","article-title":"The effectiveness of lifestyle interventions for diabetes remission on patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"20","author":"Zhang","year":"2023","journal-title":"Worldviews Evid.-Based Nurs."},{"key":"10.1016\/j.bbadis.2025.168102_bb0490","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.pop.2021.11.001","article-title":"Risk factors and lifestyle interventions","volume":"49","author":"Salzberg","year":"2022","journal-title":"Prim. Care"},{"key":"10.1016\/j.bbadis.2025.168102_bb0495","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5962001","article-title":"Use and trends of diabetes self-management technologies: a correlation-based study","volume":"2022","author":"Fontecha","year":"2022","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.bbadis.2025.168102_bb0500","doi-asserted-by":"crossref","DOI":"10.2196\/37430","article-title":"Efficacy of personalized diabetes self-care using an electronic medical record-integrated mobile app in patients with type 2 diabetes: 6-month randomized controlled trial","volume":"24","author":"Lee","year":"2022","journal-title":"J. Med. Internet Res."},{"key":"10.1016\/j.bbadis.2025.168102_bb0505","article-title":"Clinical significance of hyperuricaemia in biopsy-proven diabetic kidney disease \u2501 a single-Centre retrospective study","volume":"16","author":"Yu","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.bbadis.2025.168102_bb0510","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12937-023-00874-5","article-title":"Hip circumference has independent association with the risk of hyperuricemia in middle-aged but not in older male patients with type 2 diabetes mellitus","volume":"22","author":"Lu","year":"2023","journal-title":"Nutr. J."},{"key":"10.1016\/j.bbadis.2025.168102_bb0515","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s40265-022-01813-0","article-title":"Dorzagliatin: first approval","volume":"82","author":"Syed","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.bbadis.2025.168102_bb0520","article-title":"Multimodal machine learning-based marker enables early detection and prognosis prediction for hyperuricemia","volume":"11","author":"Zeng","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.bbadis.2025.168102_bb0525","doi-asserted-by":"crossref","first-page":"18758","DOI":"10.1021\/acs.jafc.4c03605","article-title":"Harnessing protein hydrolysates and peptides for hyperuricemia management: insights into sources, mechanisms, techniques, and future directions","volume":"72","author":"Liu","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbadis.2025.168102_bb0530","first-page":"1","article-title":"The human gut microbiota and uric acid metabolism: genes, metabolites, and diet","author":"Sun","year":"2025","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.bbadis.2025.168102_bb0535","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejim.2022.04.022","article-title":"Uric acid in metabolic syndrome: does uric acid have a definitive role?","volume":"103","author":"Copur","year":"2022","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.bbadis.2025.168102_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116753","article-title":"Design, synthesis and bioactivity evaluation of isobavachin derivatives as hURAT1 inhibitors for hyperuricemia agents","volume":"277","author":"Zhao","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbadis.2025.168102_bb0545","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202412612","article-title":"Albumin corona-coated nanoscale metal-organic framework for enzyme-mediated cascade metabolization of uric acid in hyperuricemia","volume":"21","author":"Lv","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.bbadis.2025.168102_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.129286","article-title":"Identification of natural xanthine oxidase inhibitors: virtual screening, anti-xanthine oxidase activity, and interaction mechanism","volume":"259","author":"Yu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbadis.2025.168102_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.123128","article-title":"High-affinity uric acid clearance based on motile beta-CD\/f-127 polyrotaxane microspheres for enhanced diabetic wound repair","volume":"351","author":"Jiang","year":"2025","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bbadis.2025.168102_bb0560","article-title":"The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2025.168102_bb0565","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jare.2022.11.003","article-title":"Sulforaphane-driven reprogramming of gut microbiome and metabolome ameliorates the progression of hyperuricemia","volume":"52","author":"Wang","year":"2023","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bbadis.2025.168102_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.110179","article-title":"Association between uric acid levels and incidence of type 2 diabetes: population-based panasonic cohort study 11","volume":"195","author":"Kobayashi","year":"2023","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbadis.2025.168102_bb0575","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2337\/dc22-1339","article-title":"Association of serum uric acid with all-cause and cardiovascular mortality in diabetes","volume":"46","author":"Li","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bbadis.2025.168102_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.artmed.2022.102343","article-title":"Modelling and assessing one- and two-drug dose titrations","volume":"131","author":"Riano","year":"2022","journal-title":"Artif. Intell. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925004521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925004521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T08:25:35Z","timestamp":1779524735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443925004521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":116,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0925443925004521"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.168102","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting the metabolic crosstalk between type 2 diabetes and hyperuricemia: Pathophysiological insights and therapeutic perspectives","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.168102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168102"}}